Update shared on06 Aug 2025
Fair value Decreased 21%Despite a substantial improvement in net profit margin and a sharp decline in future P/E, the consensus analyst price target for BRC has been notably reduced from $2.83 to $2.12.
What's in the News
- BRC Inc. reaffirmed earnings guidance for fiscal 2025, expecting net revenue between $395 million and $425 million.
- Completed a follow-on equity offering of $35 million, issuing 28,000,000 shares of Class A common stock at $1.25 per share.
- Dropped from multiple Russell value and small cap indices, including the Russell 2000, 2500, 3000, and related value indices.
- Settled litigation with Alta Partners, issuing 2,300,100 shares and receiving $1 million as part of the agreement.
- Appointed Matthew Amigh as Chief Financial Officer, effective July 7, 2025, bringing extensive financial and operational leadership experience.
Valuation Changes
Summary of Valuation Changes for BRC
- The Consensus Analyst Price Target has significantly fallen from $2.83 to $2.12.
- The Net Profit Margin for BRC has significantly risen from 1.35% to 3.11%.
- The Future P/E for BRC has significantly fallen from 125.99x to 19.94x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.